Application of PHASES and ELAPSS scores to ruptured cerebral aneurysms: how many would have been conservatively managed?

J Neurosurg Sci. 2021 Feb;65(1):33-37. doi: 10.23736/S0390-5616.18.04498-3. Epub 2018 May 28.

Abstract

Background: We calculated the PHASES and ELAPSS scores for a large cohort of ruptured intracranial aneurysms (RIA) in order to determine whether these RIA would have been pre-emptively treated or closely followed-up should they have been detected prior to rupture.

Methods: We retrospectively reviewed a consecutive series of RIA over a 20-year period. The primary outcome of this study was the PHASES score of each ruptured aneurysm included. Secondary outcomes were ELAPSS score and other risk factors for aneurysmal subarachnoid hemorrhage including aneurysm location, aneurysm size, aneurysm morphology, smoking and hypertension history, personal and family history of subarachnoid hemorrhage. Multiplicity of cerebral aneurysms was recorded. Descriptive statistics are reported.

Results: 700 consecutive ruptured aneurysms were included. Mean age at rupture was 56 (+/-13.5) years. Mean aneurysm size was 5.9 (+/-2.5) mm. Most common locations of ruptured aneurysms were the anterior cerebral/communicating artery (39%), posterior communicating artery (21%), middle cerebral artery (16%) and basilar terminus (7%). Mean PHASES score was 5.3 (+/-2.5) and 17% of the RIA had a PHASES score of 3 or less. Mean ELAPSS score was 13.89 (+/-7.05) and over half of the RIA included had a low risk of future growth.

Conclusions: A reasonable percentage of ruptured aneurysms have a low calculated PHASES score and these aneurysms may have been managed conservatively should they have presented incidentally prior to rupture. Most ruptured aneurysms also had a low ELAPSS score and were at low risk of future growth. The use PHASES score and ELAPSS score alone when making treatment decisions could result in many aneurysms being treated conservatively or undergoing remote surveillance despite rupture potential.

MeSH terms

  • Aneurysm, Ruptured* / therapy
  • Cerebral Angiography
  • Humans
  • Intracranial Aneurysm* / therapy
  • Retrospective Studies
  • Risk Factors
  • Subarachnoid Hemorrhage* / epidemiology
  • Subarachnoid Hemorrhage* / therapy